miR-155 enhances proliferation and migration by targeting suppressor genes like SOCS1 (101), while miR-221/222 promotes tumor progression by regulating cell cycle inhibitors like p27kip1 (102). The gene discussed is CDKN1B; the disease is neoplasm.